BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 17065155)

  • 1. The roles of substrate thermal stability and P2 and P1' subsite identity on matrix metalloproteinase triple-helical peptidase activity and collagen specificity.
    Minond D; Lauer-Fields JL; Cudic M; Overall CM; Pei D; Brew K; Visse R; Nagase H; Fields GB
    J Biol Chem; 2006 Dec; 281(50):38302-13. PubMed ID: 17065155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase triple-helical peptidase activities are differentially regulated by substrate stability.
    Minond D; Lauer-Fields JL; Nagase H; Fields GB
    Biochemistry; 2004 Sep; 43(36):11474-81. PubMed ID: 15350133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collagenolytic Matrix Metalloproteinase Activities toward Peptomeric Triple-Helical Substrates.
    Stawikowski MJ; Stawikowska R; Fields GB
    Biochemistry; 2015 May; 54(19):3110-21. PubMed ID: 25897652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissecting MMP P
    Tokmina-Roszyk M; Fields GB
    J Biol Chem; 2018 Oct; 293(43):16661-16676. PubMed ID: 30185620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of secreted and membrane-type matrix metalloproteinase activities based on substitutions and interruptions of triple-helical sequences.
    Minond D; Lauer-Fields JL; Cudic M; Overall CM; Pei D; Brew K; Moss ML; Fields GB
    Biochemistry; 2007 Mar; 46(12):3724-33. PubMed ID: 17338550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple-helical transition state analogues: a new class of selective matrix metalloproteinase inhibitors.
    Lauer-Fields J; Brew K; Whitehead JK; Li S; Hammer RP; Fields GB
    J Am Chem Soc; 2007 Aug; 129(34):10408-17. PubMed ID: 17672455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining the Substrate Specificity of Matrix Metalloproteases using Fluorogenic Peptide Substrates.
    Stawikowski MJ; Knapinska AM; Fields GB
    Methods Mol Biol; 2017; 1579():137-183. PubMed ID: 28299736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases and collagen catabolism.
    Lauer-Fields JL; Juska D; Fields GB
    Biopolymers; 2002; 66(1):19-32. PubMed ID: 12228918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Edman degradation sequence analysis and matrix-assisted laser desorption/ionization mass spectrometry in designing substrates for matrix metalloproteinases.
    Lauer-Fields JL; Nagase H; Fields GB
    J Chromatogr A; 2000 Aug; 890(1):117-25. PubMed ID: 10976799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pivotal molecular determinants of peptidic and collagen triple helicase activities reside in the S3' subsite of matrix metalloproteinase 8 (MMP-8): the role of hydrogen bonding potential of ASN188 and TYR189 and the connecting cis bond.
    Pelman GR; Morrison CJ; Overall CM
    J Biol Chem; 2005 Jan; 280(3):2370-7. PubMed ID: 15533938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic analysis of matrix metalloproteinase activity using fluorogenic triple-helical substrates.
    Lauer-Fields JL; Broder T; Sritharan T; Chung L; Nagase H; Fields GB
    Biochemistry; 2001 May; 40(19):5795-803. PubMed ID: 11341845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of matrix metalloproteinase triple-helical peptidase activity with substrates incorporating fluorogenic L- or D-amino acids.
    Lauer-Fields JL; Kele P; Sui G; Nagase H; Leblanc RM; Fields GB
    Anal Biochem; 2003 Oct; 321(1):105-15. PubMed ID: 12963061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective hydrolysis of triple-helical substrates by matrix metalloproteinase-2 and -9.
    Lauer-Fields JL; Sritharan T; Stack MS; Nagase H; Fields GB
    J Biol Chem; 2003 May; 278(20):18140-5. PubMed ID: 12642591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the distinct collagen binding, helicase and cleavage mechanisms of matrix metalloproteinase 2 and 14 (gelatinase A and MT1-MMP): the differential roles of the MMP hemopexin c domains and the MMP-2 fibronectin type II modules in collagen triple helicase activities.
    Tam EM; Moore TR; Butler GS; Overall CM
    J Biol Chem; 2004 Oct; 279(41):43336-44. PubMed ID: 15292230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The recognition of collagen and triple-helical toolkit peptides by MMP-13: sequence specificity for binding and cleavage.
    Howes JM; Bihan D; Slatter DA; Hamaia SW; Packman LC; Knauper V; Visse R; Farndale RW
    J Biol Chem; 2014 Aug; 289(35):24091-101. PubMed ID: 25008319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosite interactions impact matrix metalloproteinase collagen specificities.
    Robichaud TK; Steffensen B; Fields GB
    J Biol Chem; 2011 Oct; 286(43):37535-42. PubMed ID: 21896477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition and catabolism of synthetic heterotrimeric collagen peptides by matrix metalloproteinases.
    Ottl J; Gabriel D; Murphy G; Knäuper V; Tominaga Y; Nagase H; Kröger M; Tschesche H; Bode W; Moroder L
    Chem Biol; 2000 Feb; 7(2):119-32. PubMed ID: 10662694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple-helical peptide analysis of collagenolytic protease activity.
    Lauer-Fields JL; Fields GB
    Biol Chem; 2002; 383(7-8):1095-105. PubMed ID: 12437092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of specific hemopexin-like domain residues that facilitate matrix metalloproteinase collagenolytic activity.
    Lauer-Fields JL; Chalmers MJ; Busby SA; Minond D; Griffin PR; Fields GB
    J Biol Chem; 2009 Sep; 284(36):24017-24. PubMed ID: 19574232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective modulation of matrix metalloproteinase 9 (MMP-9) functions via exosite inhibition.
    Lauer-Fields JL; Whitehead JK; Li S; Hammer RP; Brew K; Fields GB
    J Biol Chem; 2008 Jul; 283(29):20087-95. PubMed ID: 18499673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.